IL6 and breast cancer: These results suggested that despite the downregulated proportion of MDSCs after cryo-thermal therapy, there was still residual MDSCs accompanied by the increased expression of IL-6 after treatment, which would impair the therapeutic effect of cryo-thermal therapy in the 4T1 breast cancer model.